Andrew Mundala News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A new R21/Matrix-M malaria vaccine shows 75% efficacy in a Phase2b trial - a potentially game-changing result compared to the WHO-approved RTS,S/AS01 (RTS,S)

Region du centre ouestBurkina fasoNew yorkUnited statesHalidou tintoMatshidiso moetiAndrew mundalaAdrian hillUniversity of oxfordUniversity of oxford jenner instituteMelinda gates foundationOxford biomedical research centreEuropean unionGates foundationSerum institute of indiaLancet infectious diseases